Results 171 to 180 of about 32,413 (228)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Pediatrics, 2022
Purpose of review Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination. Recent findings Pertussis cases and deaths in children are at a record low number.
James D, Cherry, Saba, Doustmohammadi
openaire +2 more sources
Purpose of review Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination. Recent findings Pertussis cases and deaths in children are at a record low number.
James D, Cherry, Saba, Doustmohammadi
openaire +2 more sources
Pediatric Clinics of North America, 1990
Concern over adverse reactions temporally associated with whole cell pertussis vaccine and advances in the understanding of the Bordetella pertussis organism have led to a new generation of more purified acellular vaccines. The biology of the pertussis organism, epidemiology of disease, vaccine development over the decades, and vaccine efficacy and ...
K M, Edwards, D T, Karzon
openaire +2 more sources
Concern over adverse reactions temporally associated with whole cell pertussis vaccine and advances in the understanding of the Bordetella pertussis organism have led to a new generation of more purified acellular vaccines. The biology of the pertussis organism, epidemiology of disease, vaccine development over the decades, and vaccine efficacy and ...
K M, Edwards, D T, Karzon
openaire +2 more sources
Pertussis vaccine controversies and acellular pertussis vaccine
The Indian Journal of Pediatrics, 2003Pertussis still continues to cause significant morbidity and mortality worldwide. Because of the high reactogenicity of whole cell pertussis vaccine, it had evoked public controversy in several countries. In 1970 Japan abandoned use of whole cell pertussis vaccine and mounted efforts to develop better vaccine.
Raju C, Shah, Anuj R, Shah
openaire +2 more sources
Epidemiology of Pertussis and Reactions to Pertussis Vaccine
Epidemiologic Reviews, 1992It remains clear that pertussis is a dangerous infectious disease that is well-controlled in industrialized countries by widespread immunization. In the developing world, it remains a source of high morbidity and mortality because of previously inadequate immunization programs.
S L, Hodder, E A, Mortimer
openaire +2 more sources
Current Problems in Pediatrics, 2000
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M R, Schleiss, K, Dahl
openaire +4 more sources
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M R, Schleiss, K, Dahl
openaire +4 more sources
Improving pertussis vaccination
Human Vaccines, 2009Despite a high vaccine coverage, pertussis has re-emerged and has become the most prevalent vaccine preventable disease in developed countries. The re-emergence of pertussis has been attributed to various factors, including increased awareness, improved diagnostics, suboptimal vaccines, waning vaccine-induced immunity and pathogen adaptation.
Guy A M, Berbers +2 more
openaire +2 more sources
Journal of Infection and Chemotherapy, 1999
Acellular pertussis vaccine has been developed and marketed in Japan since 1981, and has been used periodically, combined with diphtheria and tetanus toxoids in the form of an APDT vaccine. The acellular pertussis vaccines are manufactured, authorized, and used in Japan. The present report will briefly describe their clinical efficacy for immunization.
openaire +2 more sources
Acellular pertussis vaccine has been developed and marketed in Japan since 1981, and has been used periodically, combined with diphtheria and tetanus toxoids in the form of an APDT vaccine. The acellular pertussis vaccines are manufactured, authorized, and used in Japan. The present report will briefly describe their clinical efficacy for immunization.
openaire +2 more sources
An Evaluation of Pertussis Vaccine
Clinical Infectious Diseases, 1979Infant mortality from pertussis in the United States was 4.5 deaths/1,000 in 1900 but decreased to 0.003 deaths/1,000 by 1974. The attribution of this decrease in mortality to the widespread use of pertussis vaccine, which began in the 1940s, has been questioned because death rates from pertussis in infants steadily declined by 70% between 1900-1904 ...
E A, Mortimer, P K, Jones
openaire +2 more sources